Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Oncology Institute (DFPH) Shares Outstanding (2020 - 2022)

Historic Shares Outstanding for Oncology Institute (DFPH) over the last 3 years, with Q2 2022 value amounting to $72.0 million.

  • Oncology Institute's Shares Outstanding rose 902.59% to $72.0 million in Q2 2022 from the same period last year, while for Jun 2022 it was $72.0 million, marking a year-over-year increase of 902.59%. This contributed to the annual value of $73.2 million for FY2021, which is 2381.47% up from last year.
  • According to the latest figures from Q2 2022, Oncology Institute's Shares Outstanding is $72.0 million, which was up 902.59% from $73.3 million recorded in Q1 2022.
  • Oncology Institute's Shares Outstanding's 5-year high stood at $73.3 million during Q1 2022, with a 5-year trough of $5.8 million in Q1 2020.
  • Over the past 3 years, Oncology Institute's median Shares Outstanding value was $62.6 million (recorded in 2020), while the average stood at $43.3 million.
  • Over the last 5 years, Oncology Institute's Shares Outstanding had its largest YoY gain of 104820.57% in 2021, and its largest YoY loss of 0.0% in 2021.
  • Over the past 3 years, Oncology Institute's Shares Outstanding (Quarter) stood at $59.2 million in 2020, then rose by 23.81% to $73.2 million in 2021, then decreased by 1.73% to $72.0 million in 2022.
  • Its Shares Outstanding stands at $72.0 million for Q2 2022, versus $73.3 million for Q1 2022 and $73.2 million for Q4 2021.